<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Parry, Nicola</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Krum, Henry</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Catheter-Based Renal Artery Denervation – Sustained Blood Pressure Lowering with Reassuring Safety at 3 Years</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">Catheter-based renal artery denervation appears to result in sustained blood pressure (BP) reduction with a favorable safety profile in patients through 3 years with consistent benefit across age, diabetes status, and renal function. This article presents the final 3-year results from the Renal Denervation in Patients With Refractory Hypertension trial [Symplicity HTN-1; NCT00664638].</style></abstract><number><style face="normal" font="default" size="100%">15</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>